Sarcoma Biopsy Market Revenue, Financials, Competitive Landscape with Driving Factors By 2026 | C. R. Bard, Inc., Becton, Dickinson and Company, Argon Medical Devices

Sarcoma is a type of cancer, which occurs in connective tissues. Moreover, sarcoma is broadly classified into two types such as soft tissue sarcoma and bone sarcoma. Soft tissue sarcomas occur in tissues of blood vessels, nerves, tendons, muscles, fat, and lining of the joints. Soft tissue sarcomas are mostly found in legs, arms, abdomen, and chest. There are over 50 types of soft tissue sarcoma. Soft tissue sarcoma symptoms include lump growth, abdominal pain, blood in stools, and vomiting.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/3819

Market Dynamics

The global sarcoma biopsy market is expected to witness significant growth during the forecast period, owing to increasing prevalence of bone cancer. For instance, according to the American Society of Clinical Oncology, in 2018, around 3,450 new cases of bone cancer were registered and total 1,590 deaths occurred due to bone cancer in the U.S.

Bone cancer can be diagnosed using imaging techniques such as computerized tomography (CT), bone scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and biopsy tests.

Increasing prevalence of osteosarcoma is expected to drive growth of the global sarcoma biopsy market.

Osteosarcoma is the most common type of cancer affecting bones, and it mostly occurs in children and young adults. On the basis of cells, osteosarcoma is classified as high-, intermediate- and low-grade. For instance, according to the American Cancer Society, IN January 2020, around 800 to 900 new cases of osteosarcoma are diagnosed in the U.S. each year, with around 50% occurs in children and teenagers.

There are different type of biopsy procedures used to diagnose osteosarcoma such as needle biopsy and surgical biopsy.

Global Sarcoma Biopsy Market– Regional Analysis

North America accounted for the largest market share in the global sarcoma biopsy market, owing to rising healthcare expenditure in the U.S. For instance, according to the Committee for a Responsible Federal Budget, in 2017, the U.S. spent around US $ 3.5 trillion, or 18% of the total GDP, on health expenditures, which is more than twice the average among developed countries.

Furthermore, Asia Pacific is also expected to witness significant growth in the global sarcoma biopsy market, owing to increasing healthcare facilities. For instance, according to the India Brand Equity Foundation, in 2015 around 156,926 sub centers, and 196,312 hospitals are present in India.

Detailed Segmentation:

Global Sarcoma Biopsy Market, By Product Type:
Reusable Devices
Disposable Devices

Global Sarcoma Biopsy Market, By End User:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers

Global Sarcoma Biopsy Market, By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa

Buy Now This Research Report: https://www.coherentmarketinsights.com/insight/buy-now/3819

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.